| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Operating Officer
1 company
Raday Gilead is a Chief Operating Officer at RDHL. Recent filings cover 0 purchases and 3 sales. Those positions are worth an estimated $18K at current prices.
Raday Gilead's largest disclosed position is in RDHL as Chief Operating Officer, worth about $18K. The recent filings there lean toward selling, a net 44,180,000 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Oct 1, 2026 | RDHL Redhill Biopharma Ltd. | Chief Operating Officer | Sale+OE | 14,310,000 | $0.00 | $1,431.00 | -7.5% | |
| Jul 10, 2026 | RDHL Redhill Biopharma Ltd. | Chief Operating Officer | Sale+OE | 14,130,000 | $0.00 | $1,413.00 | -6.1% | |
| Apr 6, 2026 | RDHL Redhill Biopharma Ltd. | Chief Operating Officer | Sale+OE | 15,740,000 | $0.00 | $1,574.00 | -5.7% |